The phrase "an interesting trial" is correct and usable in written English.
You can use it when describing a trial that captures attention or provokes curiosity, often in a legal or experimental context.
Example: "The researchers conducted an interesting trial to test the effectiveness of the new drug."
Alternatives: "a fascinating trial" or "a compelling trial".
One such early partner is Dominos Pizza — because self-driving cars for pizza deliveries… — while has been testing the social aspect of self-driving cars through an interesting trial that featured a man driving a car while disguised as a seat.
Mullen sent up an interesting trial balloon at a July 2 , 2008 press conference, when he indicated that military-to-military dialogue could "add to a better understanding" between the U.S. and Iran.
This is an interesting trial and the first of which we are aware to test the efficacy of GDT in this patient group.
Furthermore, suppression of MK gene expression using a recently developed RNAi technology during pathogenesis and progression of pancreatic head carcinoma may be an interesting trial for possible inhibition of this disease.
In 2009 Delgado et al. performed an interesting trial with the aim to evaluate the GFR burden on b2m prognostic value in a cohort of 450 subjects affected by chronic lymphocytic leukaemia; they used a multivariate analysis method displaying a significantly better prognostic value of this marker adjusting the value for the GFR [ 53].
Thus, an interesting trial for patients who have had the primary cancer removed but still had synchronous liver metastases in place is one randomizing these patients to 6 continuous months of chemotherapy before liver resection, versus treating them with 2 to 3 months of chemotherapy followed by resection and then adjuvant therapy.
In an interesting recent trial [27], sequential estimation of PT-international normalized ratio (INR) was a strong predictor of the efficacy of treatment.
In an interesting clinical trial, the chondrocytes of patients have been modified to produce the transforming growth factor β1 via intra-articular injection, showing a dose-dependent trend toward efficacy.
Clearly there is a need for further simulation work involving many interesting trial variables whose spread of values, individually and in combination could be explored.
One very interesting trial is the ongoing prospective observational PESA study [ 30].
This interesting trial adds another piece to the jigsaw of optimal peri-operative hemodynamic therapy.
